Literature DB >> 14762255

Studying host immune responses against duck hepatitis B virus infection.

Darren S Miller1, Edward M Bertram, Catherine A Scougall, Ieva Kotlarski, Allison R Jilbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14762255     DOI： 10.1385/1-59259-670-3:3

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  5 in total

1.  Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

Authors:  Wendy K Foster; Darren S Miller; Catherine A Scougall; Ieva Kotlarski; Richard J Colonno; Allison R Jilbert
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.

Authors:  Marc F Le Mire; Darren S Miller; Wendy K Foster; Christopher J Burrell; Allison R Jilbert
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.

Authors:  Faseeha Noordeen; Andrew Vaillant; Allison R Jilbert
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

4.  Duck Hepatitis B Virus cccDNA Amplification Efficiency in Natural Infection Is Regulated by Virus Secretion Efficiency.

Authors:  Yong-Yuan Zhang
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

5.  Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.

Authors:  Faseeha Noordeen; Catherine A Scougall; Arend Grosse; Qiao Qiao; Behzad B Ajilian; Georget Reaiche-Miller; John Finnie; Melanie Werner; Ruth Broering; Joerg F Schlaak; Andrew Vaillant; Allison R Jilbert
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.